Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 26, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 26, Issue 11 (2017)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 26, Issue 11 (2017)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Volume 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Targeting triple negative breast cancer with histone deacetylase inhibitors

Palma Fedele, Laura Orlando & Saverio Cinieri

Pages: 1199-1206

Published online: 08 Oct 2017

AbstractforTargeting triple negative breast cancer with histone deacetylase inhibitors | Full Text | References | PDF (675.1 KB)

823 Views
48 CrossRef citations
0Altmetric

Review

Investigational HIV integrase inhibitors in phase I and phase II clinical trials

Yingshan Han, Thibault Mesplède & Mark A. Wainberg

Pages: 1207-1213

Published online: 28 Sep 2017

AbstractforInvestigational HIV integrase inhibitors in phase I and phase II clinical trials | Full Text | References | PDF (620.3 KB)

772 Views
15 CrossRef citations
0Altmetric

Review

Beneficial effects of bile acid receptor agonists in pulmonary disease models

Paolo Comeglio, Annamaria Morelli, Luciano Adorini, Mario Maggi & Linda Vignozzi

Pages: 1215-1228

Published online: 03 Oct 2017

AbstractforBeneficial effects of bile acid receptor agonists in pulmonary disease models | Full Text | References | PDF (1.4 MB)

842 Views
17 CrossRef citations
0Altmetric

Review

Clinical development of mTor inhibitors for renal cancer

Michele Ghidini, Fausto Petrelli, Antonio Ghidini, Gianluca Tomasello, Jens Claus Hahne, Rodolfo Passalacqua & Sandro Barni

Pages: 1229-1237

Published online: 03 Oct 2017

AbstractforClinical development of mTor inhibitors for renal cancer | Full Text | References | PDF (708.1 KB)

431 Views
38 CrossRef citations
0Altmetric

Review

Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia

Adamantia Liapikou, Catia Cillóniz & Antoni Torres

Pages: 1239-1248

Published online: 03 Oct 2017

AbstractforInvestigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia | Full Text | References | PDF (901.7 KB)

298 Views
7 CrossRef citations
0Altmetric

Review

Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia

Pawel Robak & Tadeusz Robak

Pages: 1249-1265

Published online: 03 Oct 2017

AbstractforNovel synthetic drugs currently in clinical development for chronic lymphocytic leukemia | Full Text | References | PDF (1.5 MB)

817 Views
31 CrossRef citations
0Altmetric

Review

PI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma

Benjamin L. Lampson & Jennifer R. Brown

Pages: 1267-1279

Published online: 06 Oct 2017

AbstractforPI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma | Full Text | References | PDF (1.2 MB)

803 Views
57 CrossRef citations
0Altmetric

Review

Investigational drugs in phase II clinical trials for the treatment of neuroblastoma

Loredana Amoroso, Riccardo Haupt, Alberto Garaventa & Mirco Ponzoni

Pages: 1281-1293

Published online: 26 Sep 2017

AbstractforInvestigational drugs in phase II clinical trials for the treatment of neuroblastoma | Full Text | References | PDF (1.1 MB)

495 Views
16 CrossRef citations
0Altmetric

Drug Evaluation

Article

Safety and efficacy of nintedanib for the treatment of metastatic colorectal cancer

Maria Carmen Riesco-Martinez, Ana Sanchez-Torre & Rocio Garcia-Carbonero

Pages: 1295-1305

Published online: 06 Oct 2017

AbstractforSafety and efficacy of nintedanib for the treatment of metastatic colorectal cancer | Full Text | References | PDF (992.7 KB)

305 Views
4 CrossRef citations
0Altmetric

Article

Venetoclax for the treatment of chronic lymphocytic leukemia

Massimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, Ernesto Vigna, Anna Grazia Recchia, Nadia Caruso, Sabrina Bossio, Laura De Stefano, Angela Palummo, Francesca Storino, Massimo Martino & Fortunato Morabito

Pages: 1307-1316

Published online: 09 Oct 2017

AbstractforVenetoclax for the treatment of chronic lymphocytic leukemia | Full Text | References | PDF (1 MB)

1618 Views
44 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Early psoriatic arthritis: clinical and therapeutic challenges.

Francesco Caso et al.

Review Article | Published online: 23 Jul 2024

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents

Elisabeth Amadeo et al.

Review Article | Published online: 22 Jul 2024

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H. Gaffey et al.

Review Article | Published online: 17 Jul 2024

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.26, Iss.11, 2017)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?